From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast - could or should Boohoo.com go bust?

By Tom Winnifrith | Monday 29 August 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with a nasty shock my grandmother, Lesbia Cochrane, got in the late 1920s. This is relevant I suggest that a whole swathe of millenials could be getting a similar shock this year and that is one of many reasons why I pose the Boohoo (BOO) question. I look at its balance sheet, cashflows, shocking G ( as in ESG) and find myself agreeing with ouzo man. Thewn the chart below and what it means for any company including Purplebricks (PURP) , getting some PR dictated puffery in The Times today, exposed to UK housing. Finally it is 12 days to ShareStock. I am off to mow the lawn for the tents next, book your seats HERE

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 07:43:46